• Viral infections

Viral infections:

Indications for XOFLUZA:

Treatment of acute uncomplicated influenza in patients who have been symptomatic for no more than 48hrs.

Limitations of Use:

Consider available information on drug susceptibility patterns for circulating influenza strains when deciding whether to use.

Adult:

Start within 48hrs of symptom onset. ≥12yrs (40–<80kg): 40mg as a single dose; (≥80kg): 80mg as a single dose.

Children:

<12yrs (or <40kg): not established.

Warnings/Precautions:

Potential secondary bacterial infections; treat appropriately. Pregnancy. Nursing mothers.

Pharmacologic Class:

Polymerase acidic (PA) endonuclease inhibitor.

Interactions:

Avoid co-administration with dairy products, calcium-fortified beverages, polyvalent cation-containing laxatives, antacids, or oral supplements (eg, calcium, iron, magnesium, selenium, or zinc). May reduce efficacy of live attenuated influenza vaccines.

Adverse Reactions:

Diarrhea, bronchitis, nasopharyngitis, headache, nausea.

Generic Availability:

NO

How Supplied:

Tabs—2

Pricing for XOFLUZA

2 tablets of 40mg dose pack (Qty: 1)
Appx. price $157
GoodRx